Photochromic Indolyl Fulgimides as Chromo-pharmacophores Targeting Sirtuins
- 1 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 83 (15) , 7919-7927
Abstract
Sirtuins are involved in epigenetic regulation, the pathogenesis of cancer and, several metabolic and neurodegenerative dis-eases. Though being a promising drug target, only one small molecule passed class II clinical trials so far. Deriving a better mechanistic understanding is hence crucial to find new modulators. We previously reported on a series of dithienyl maleimides as photochromic tool compounds. However, their photochromic behavior was limited. To improve the interconversion and stability of both photoisomers, we replaced the dithienyl maleimide with a fulgimide as photochromic core to result in biologically active compounds reversibly addressable with purple and orange light. We characterize the obtained compounds regarding their spectroscopic properties, their photostability and binding characteristics towards sirtuins resulting in a fully remote-controllable Sirtuin modulator using visible light as the external stimulant.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Ju295/14-1)
- Studienstiftung des Deutschen Volkes
This publication has 33 references indexed in Scilit:
- An exploratory double‐blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's diseaseBritish Journal of Clinical Pharmacology, 2014
- Histone deacetylase inhibitorsAnti-Cancer Drugs, 2014
- Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective InhibitorsJournal of Medicinal Chemistry, 2012
- Overexpression of SIRT2 contributes tumor cell growth in hepatocellular carcinomasMolecular & Cellular Toxicology, 2011
- Synthesis and biological activity of splitomicin analogs targeted at human NAD+-dependent histone deacetylases (sirtuins)Bioorganic & Medicinal Chemistry, 2011
- Inhibitors to understand molecular mechanisms of NAD+-dependent deacetylases (sirtuins)Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins)ChemMedChem, 2007
- Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, from Kinase to Sirtuin InhibitionJournal of Medicinal Chemistry, 2006
- Sirtuins: Sir2-related NAD-dependent protein deacetylasesGenome Biology, 2004
- Phylogenetic Classification of Prokaryotic and Eukaryotic Sir2-like ProteinsBiochemical and Biophysical Research Communications, 2000